8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate has been researched along with Osteosarcoma in 1 studies
8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate: intracellular calcium antagonist; RN given refers to parent cpd
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iida-Klein, A | 1 |
| Hahn, TJ | 1 |
1 other study available for 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Osteosarcoma
| Article | Year |
|---|---|
Insulin acutely suppresses parathyroid hormone second messenger generation in UMR-106-01 osteoblast-like cells: differential effects on phospholipase C and adenylate cyclase activation.
Topics: Adenylyl Cyclases; Animals; Calcium; Enzyme Activation; Gallic Acid; Inositol Phosphates; Insulin; N | 1991 |